Konishi Hiroki, Sudo Masatomo, Sumi Masaki, Morii Hiroaki, Minouchi Tokuzo, Aimoto Tachio, Yamaji Akira
Department of Hospital Pharmacy, Shiga University of Medical Science, Seta, Otsu, Japan.
Biol Pharm Bull. 2005 Mar;28(3):556-9. doi: 10.1248/bpb.28.556.
We examined the pharmacokinetic behavior of micafungin, a novel antifungal agent, in rats receiving carbon tetrachloride (CCl4) at a single dose of 2.5 ml/kg. There was no significant change in the total clearance (CL(tot)) in CCl4-treated rats, while the steady-state volume of distribution (Vd(ss)) was significantly increased by CCl4 treatment. Alteration in the serum unbound fraction of micafungin after CCl4 treatment was unlikely in light of the serum albumin, bilirubin, creatinine, and urea nitrogen. The increased Vd(ss) was attributable to augmentation in the accessibility of micafungin to peripheral tissue without impairment of the intrinsic clearance, because slight enhancement of the tissue distribution of micafungin was confirmed following CCl4 treatment.
我们研究了新型抗真菌药物米卡芬净在接受单次剂量为2.5 ml/kg四氯化碳(CCl4)的大鼠体内的药代动力学行为。CCl4处理的大鼠的总清除率(CL(tot))没有显著变化,而CCl4处理使稳态分布容积(Vd(ss))显著增加。鉴于血清白蛋白、胆红素、肌酐和尿素氮,CCl4处理后米卡芬净的血清未结合分数不太可能发生改变。Vd(ss)的增加归因于米卡芬净在外周组织中的可及性增加,而固有清除率未受损,因为CCl4处理后证实米卡芬净的组织分布略有增强。